Company / Cost of Revenue
NEPHROS INC Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$7.2M
FY2025
5-year range
$4.6M / $7.2M
FY2021-FY2025
Trend
+22.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $5M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +14.5%.
Increased from $5M to $7M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +11.0%
- 5-Year CAGR
- +14.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +14.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 22.8% year-over-year.
- Lowest cost of revenue in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.2M | +22.8% |
| FY2024 | $5.8M | +11.2% |
| FY2023 | $5.2M | +0.0% |
| FY2022 | $5.2M | +14.4% |
| FY2021 | $4.6M | +25.7% |
| FY2020 | $3.6M | -14.2% |
| FY2019 | $4.3M | +71.1% |
| FY2018 | $2.5M | +142.1% |
| FY2017 | $1.0M | +0.0% |
| FY2016 | $1.0M | +16.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026